Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does skin cholesterol testing provide benefit?

Chuong Ho

    Issues in Emerging Health Technologies
    |August 28, 2002
    PubMed
    Summary
    This summary is machine-generated.

    Cholesterol 1,2,3 9 (TM) offers a non-invasive method to measure skin cholesterol. While showing a correlation with coronary arterial lesions, further research is needed to confirm its clinical significance.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Economic assessment of different modalities of immunoglobulin replacement therapy.

    Immunology and allergy clinics of North America·2008
    Same author

    Meta-analysis of clinical efficacy and bleeding risk with intravenous glycoprotein IIb/IIIa antagonists for percutaneous coronary intervention.

    The Canadian journal of cardiology·2007
    Same author

    Using a spectral reflectance technique to measure transcutaneous bilirubin in neonates: a new device.

    Issues in emerging health technologies·2002
    Same journal

    Laparoscopic diaphragm pacing for tetraplegia.

    Issues in emerging health technologies·2009
    Same journal

    Implantable hemodynamic monitoring (the Chronicle IHM system): remote telemonitoring for patients with heart failure.

    Issues in emerging health technologies·2008
    Same journal

    Rotigotine transdermal patches (Neupro) for the treatment of Parkinson's disease.

    Issues in emerging health technologies·2008
    Same journal

    Continuous erythropoietin receptor activator (Mircera) for renal anemia.

    Issues in emerging health technologies·2008
    Same journal

    Milnacipran for fibromyalgia.

    Issues in emerging health technologies·2008
    Same journal

    Maraviroc (Celsentri) for multidrug-resistant human immunodeficiency virus (HIV)-1.

    Issues in emerging health technologies·2007
    See all related articles

    Area of Science:

    • Dermatology
    • Cardiology
    • Medical Device Technology

    Background:

    • Cholesterol 1,2,3 9 (TM) is a novel non-invasive device for measuring skin cholesterol accumulation.
    • The device received Health Canada licensing in 2001 and U.S. Food and Drug Administration (FDA) approval in 2002.

    Purpose of the Study:

    • To evaluate the potential of skin cholesterol measurement as a non-invasive diagnostic tool.
    • To explore the correlation between elevated skin cholesterol levels and coronary artery disease severity.

    Main Methods:

    • Utilized non-randomized, non-blinded clinical trials.
    • Assessed the relationship between skin cholesterol levels measured by Cholesterol 1,2,3 9 (TM) and coronary arterial lesions.

    Main Results:

    Related Experiment Videos

    • Preliminary evidence suggests a correlation between higher skin cholesterol levels and the presence of severe coronary arterial lesions.
    • The test is not recommended for general population screening for coronary artery disease.

    Conclusions:

    • Technical improvements and more rigorous evidence are necessary to establish the clinical utility of this skin cholesterol measurement technology.
    • Further studies are required to determine the definitive significance of this non-invasive method in clinical practice.